Further, patients may be subjected retroactively to step therapy when they change insurers, forcing them to halt an effective therapy until they can document failure of a “preferred” medication. Breaks in continuity of care risk altering the impact of the drug that was previously working for the patient, as well as the return of often debilitating symptoms.
Learn what you can do to help get this law passed in the ACR’s Legislative Action Center.